Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$30.1M Buy
228,472
+108,152
+90% +$13.3M 0.24% 86
2023
Q4
$13.1M Buy
120,320
+1,896
+2% +$197K 0.18% 119
2023
Q3
$12.2M Buy
118,424
+4,556
+4% +$491K 0.19% 114
2023
Q2
$13.1M Buy
113,868
+8,326
+8% +$945K 0.21% 108
2023
Q1
$11.2M Sell
105,542
-14,564
-12% -$1.57M 0.19% 120
2022
Q4
$13.3M Buy
120,106
+25,519
+27% +$2.61M 0.24% 90
2022
Q3
$8.15M Sell
94,587
-5,733
-6% -$512K 0.22% 107
2022
Q2
$9.15M Buy
100,320
+8,812
+10% +$781K 0.21% 107
2022
Q1
$7.51M Buy
91,508
+3,636
+4% +$287K 0.15% 140
2021
Q4
$6.74M Sell
87,872
-12,022
-12% -$958K 0.14% 155
2021
Q3
$7.5M Buy
99,894
+16,053
+19% +$1.22M 0.15% 149
2021
Q2
$6.52M Sell
83,841
-111
-0.1% -$8.26K 0.15% 140
2021
Q1
$6.17M Buy
83,952
+11,888
+16% +$877K 0.17% 130
2020
Q4
$5.63M Buy
72,064
+5,247
+8% +$401K 0.18% 115
2020
Q3
$5.29M Buy
66,817
+1,902
+3% +$149K 0.2% 106
2020
Q2
$4.79M Buy
64,915
+3,351
+5% +$252K 0.2% 104
2020
Q1
$4.52M Buy
61,564
+230
+0.4% +$18.1K 0.24% 92
2019
Q4
$5.32M Sell
61,334
-899
-1% -$73.8K 0.23% 99
2019
Q3
$5M Sell
62,233
-2,256
-3% -$181K 0.22% 103
2019
Q2
$5.17M Buy
64,489
+9,138
+17% +$700K 0.23% 102
2019
Q1
$4.39M Buy
55,351
+1,273
+2% +$95.2K 0.22% 110
2018
Q4
$3.94M Sell
54,078
-2,245
-4% -$158K 0.23% 105
2018
Q3
$3.81M Buy
56,323
+13,278
+31% +$846K 0.19% 124
2018
Q2
$2.49M Sell
43,045
-324
-0.7% -$18.3K 0.14% 156
2018
Q1
$2.25M Sell
43,369
-1,899
-4% -$103K 0.14% 168
2017
Q4
$2.42M Sell
45,268
-5,198
-10% -$288K 0.15% 144
2017
Q3
$3.08M Sell
50,466
-532
-1% -$32.3K 0.19% 128
2017
Q2
$3.12M Sell
50,998
-3,005
-6% -$183K 0.2% 121
2017
Q1
$3.27M Buy
54,003
+2,368
+5% +$144K 0.22% 103
2016
Q4
$2.9M Buy
51,635
+630
+1% +$36.9K 0.22% 108
2016
Q3
$3.03M Sell
51,005
-755
-1% -$44.2K 0.23% 96
2016
Q2
$2.85M Sell
51,760
-1,189
-2% -$63.3K 0.22% 106
2016
Q1
$2.67M Sell
52,949
-512
-1% -$25.1K 0.22% 109
2015
Q4
$2.7M Buy
53,461
+3,468
+7% +$175K 0.23% 107
2015
Q3
$2.36M Buy
49,993
+3,294
+7% +$175K 0.22% 112
2015
Q2
$2.53M Buy
46,699
+6,940
+17% +$389K 0.22% 119
2015
Q1
$2.17M Buy
39,759
+1,566
+4% +$88.7K 0.2% 129
2014
Q4
$2.07M Buy
38,193
+233
+0.6% +$13K 0.2% 123
2014
Q3
$2.14M Buy
37,960
+2,769
+8% +$155K 0.16% 112
2014
Q2
$1.94M Sell
35,191
-67
-0.2% -$3.65K 0.22% 117
2014
Q1
$1.91M Buy
35,258
+3,891
+12% +$201K 0.26% 87
2013
Q4
$1.5M Sell
31,367
-3,592
-10% -$164K 0.22% 111
2013
Q3
$1.59M Buy
34,959
+5,507
+19% +$251K 0.28% 87
2013
Q2
$1.31M Buy
+29,452
New +$1.32M 0.27% 103

Other funds holding MRK

Cetera Advisors's MRK Position: Q1 2024 in Review

Cetera Advisors increased its Merck (MRK) stake by 90% in Q1 2024, buying an estimated $13.3M and bringing the position to 228,472 shares worth $30.1M. The position accounts for 0.24% of the portfolio, ranked #86.

Cetera Advisors first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Cetera Advisors held 228,472 shares of Merck worth $30.1M as of Q1 2024.
  • Cetera Advisors bought 108,152 Merck shares in Q1 2024, an estimated $13.3M.
  • Merck made up 0.24% of Cetera Advisors's portfolio in Q1 2024, its #86 holding.
  • Cetera Advisors first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.